Currently, there are limited methods for assessing the quality of oocytes, to determine if they have the potential to be fertilized and developed into viable embryos.
Our oocyte evaluation product will give patients and clinicians more confidence about the development competence of oocytes obtained.
This enables clinicians to make highly accurate decisions about oocyte cryopreservation or additional IVF cycles. This will also be useful for selecting batches of donor oocytes.
With 15 clinics globally already committed, we are looking to expand the collaboration, ensuring it has access to a large and globally diverse dataset to underpin development of the commercial product.
